Remotely acting SMCHD1 gene regulatory elements: in silico prediction and identification of potential regulatory variants in patients with FSHD

Human Genomics

Nadia Chuzhanova²  Meena Upadhyaya⁴  David N. Cooper⁴  Dirk A. Kleinjan³  Rebecca L. Martin²  Maggie Williams¹  Debbie Smith¹  Mihir Anant Kamat⁵  Daniel S. Buxton²  Jincy Winston⁴  Taniesha Morgan⁴  Mary B. Mayes² 

[1] Blood Sciences Department and Bristol Genetics Laboratory, Southmead Hospital, Westbury-on-Trym BS10 5NB, Bristol, UK;School of Science and Technology, Nottingham Trent University, Clifton Lane, Nottingham NG11 8NS, UK;MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK;Institute of Medical Genetics, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK;Present address: Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK

关键词: FSHD;    SMCHD1;    Hi-C data;    Regulatory elements;    Regulatory mutations;   

Others  :  1229104
DOI  :  10.1186/s40246-015-0047-x

 received in 2015-07-31, accepted in 2015-10-01,  发布年份 2015

【 摘 要 】

Background

Facioscapulohumeral dystrophy (FSHD) is commonly associated with contraction of the D4Z4 macro-satellite repeat on chromosome 4q35 (FSHD1) or mutations in the SMCHD1 gene (FSHD2). Recent studies have shown that the clinical manifestation of FSHD1 can be modified by mutations in the SMCHD1 gene within a given family. The absence of either D4Z4 contraction or SMCHD1 mutations in a small cohort of patients suggests that the disease could also be due to disruption of gene regulation. In this study, we postulated that mutations responsible for exerting a modifier effect on FSHD might reside within remotely acting regulatory elements that have the potential to interact at a distance with their cognate gene promoter via chromatin looping. To explore this postulate, genome-wide Hi-C data were used to identify genomic fragments displaying the strongest interaction with the SMCHD1 gene. These fragments were then narrowed down to shorter regions using ENCODE and FANTOM data on transcription factor binding sites and epigenetic marks characteristic of promoters, enhancers and silencers.

Results

We identified two regions, located respectively ~14 and ~85 kb upstream of the SMCHD1 gene, which were then sequenced in 229 FSHD/FSHD-like patients (200 with D4Z4 repeat units <11). Three heterozygous sequence variants were found ~14 kb upstream of the SMCHD1 gene. One of these variants was found to be of potential functional significance based on DNA methylation analysis. Further functional ascertainment will be required in order to establish the clinical/functional significance of the variants found.

Conclusions

In this study, we propose an improved approach to predict the possible locations of remotely acting regulatory elements that might influence the transcriptional regulation of their associated gene(s). It represents a new way to screen for disease-relevant mutations beyond the immediate vicinity of the specific disease gene. It promises to be useful for investigating disorders in which mutations could occur in remotely acting regulatory elements.

【 授权许可】

   
2015 Mayes et al.

【 图 表 】

Fig. 1.

Fig. 2.

Fig. 3.

【 参考文献 】

• [1]Richards M, Coppée F, Thomas N, Belayew A, Upadhyaya M: Facioscapulohumeral muscular dystrophy (FSHD): an enigma unravelled? Hum Genet 2013, 131:325-40.
• [2]Wijmenga C, Hewitt JE, Sandkuijl LA, Clark LN, Wright TJ, Dauwerse HG, et al.: Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat Genet 1992, 2:26-30.
• [3]Upadhyaya M, Cooper DN: Facioscapulohumeral muscular dystrophy. Clinical medicine and molecular cell biology. Garland Science/BIOS Scientific Publishers, Oxford, UK; 2004.
• [4]Lemmers RJ, van der Vliet PJ, Klooster R, Sacconi S, Camaño P, Dauwerse JG, et al.: A unifying genetic model for facioscapulohumeral muscular dystrophy. Science 2010, 329:1650-3.
• [5]Lemmers RJ, Tawil R, Petek LM, Balog J, Block GJ, Santen GW, et al.: Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2. Nat Genet 2012, 44:1370-4.
• [6]Zeng W, de Greef JC, Chen YY, Chien R, Kong X, Gregson HC, et al.: Specific loss of histone H3 lysine 9 trimethylation and HP1gamma/cohesin binding at D4Z4 repeats is associated with facioscapulohumeral dystrophy (FSHD). PLoS Genet 2009, 5:e1000559.
• [7]Yao Z, Snider L, Balog J, Lemmers RJ, Van Der Maarel SM, Tawil R, Tapscott SJ: DUX4-induced gene expression is the major molecular signature in FSHD skeletal muscle. Hum Mol Genet 2014, 23:5342-52.
• [8]Lemmers RJ, Goeman JJ, van der Vliet PJ, van Nieuwenhuizen MP, Balog J, Vos-Versteeg M, et al.: Inter-individual differences in CpG methylation at D4Z4 correlate with clinical variability in FSHD1 and FSHD2. Hum Mol Genet 2015, 24:659-69.
• [9]Sacconi S, Lemmers RJ, Balog J, van der Vliet PJ, Lahaut P, van Nieuwenhuizen MP, et al.: The FSHD2 gene SMCHD1 is a modifier of disease severity in families affected by FSHD1. Am J Hum Genet 2013, 93:744-51.
• [10]Winston J, Duerden L, Mort M, Frayling IM, Rogers MT, Upadhyaya M: Identification of two novel SMCHD1 sequence variants in families with FSHD-like muscular dystrophy. Eur J Hum Genet 2015, 23:67-71.
• [11]Larsen M, Rost S, El Hajj N, Ferbert A, Deschauer M, Walter MC, et al.: Diagnostic approach for FSHD revisited: SMCHD1 mutations cause FSHD2 and act as modifiers of disease severity in FSHD1. Eur J Hum Genet 2015, 23:808-16.
• [12]Dekker J: Gene regulation in the third dimension. Science 2008, 319:1793-4.
• [13]Bhatia S, Kleinjan DA: Disruption of long-range gene regulation in human genetic disease: a kaleidoscope of general principles, diverse mechanisms and unique phenotypic consequences. Hum Genet 2014, 133:815-45.
• [14]Lieberman-Aiden E, van Berkum NL, Williams L, Imakaev M, Ragoczy T, Telling A, et al.: Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science 2009, 326:289-93.
• [15]Rao SS, Huntley MH, Durand NC, Stamenova EK, Bochkov ID, Robinson JT, et al.: A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell 2014, 59:1665-80.
• [16]Mifsud B, Tavares-Cadete F, Young AN, Sugar R, Schoenfelder S, Ferreira L, et al.: Mapping long-range promoter contacts in human cells with high-resolution capture Hi-C. Nat Genet 2015, 47:598-606.
• [17]Thurman RE, Rynes E, Humbert R, Vierstra J, Maurano MT, Haugen E, et al.: The accessible chromatin landscape of the human genome. Nature 2012, 489:75-82.
• [18]Creyghton MP, Cheng AW, Welstead GG, Kooistra T, Carey BW, Steine EJ, et al.: Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci U S A 2010, 107:21931-6.
• [19]Harmston N, Lenhard B: Chromatin and epigenetic features of long-range gene regulation. Nucleic Acids Res 2013, 41:7185-99.
• [20]Pollard KS, Hubisz MJ, Siepel A: Detection of non-neutral substitution rates on mammalian phylogenies. Genome Res 2010, 20:110-21.
• [21]Hartweck LM, Anderson LJ, Lemmers RJ, Dandapat A, Toso EA, Dalton JC, et al.: A focal domain of extreme demethylation within D4Z4 in FSHD2. Neurology 2013, 80:392-9.
• [22]Jones TI, Yan C, Sapp PC, McKenna-Yasek D, Kang PB, Quinn C, et al.: Identifying diagnostic DNA methylation profiles for facioscapulohumeral muscular dystrophy in blood and saliva using bisulfite sequencing. Clin Epigenetics 2014, 6:23. BioMed Central Full Text
• [23]Huichalaf C, Micheloni S, Ferri G, Caccia R, Gabellini D: DNA methylation analysis of the macrosatellite repeat associated with FSHD muscular dystrophy at single nucleotide level. PLoS One 2014, 9:e115278.
• [24]Daxinger L, Tapscott SJ, van der Maarel SM: Genetic and epigenetic contributors to FSHD. Curr Opin Genet Dev 2015, 33:56-61.
• [25]Hamby SE, Reviriego P, Cooper DN, Upadhyaya M, Chuzhanova N: Screening in silico predicted remotely acting NF1 gene regulatory elements for mutations in patients with neurofibromatosis type 1. Hum Genomics 2013, 7:18. BioMed Central Full Text
• [26]Dunham I, Kundaje A, Aldred SF, Collins PJ, Davis CA, Doyle F, et al.: ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489:57-74.
• [27]Andersson R, Gebhard C, Miguel-Escalada I, Hoof I, Bornholdt J, Boyd M, et al.: An atlas of active enhancers across human cell types and tissues. Nature 2014, 507:455-61.